ORIGINAL RESEARCH article

Front. Pharmacol., 28 January 2016

Sec. Pharmacology of Anti-Cancer Drugs

Volume 6 - 2015 | https://doi.org/10.3389/fphar.2015.00313

RETRACTED: Mechanism of Action of the Novel Nickel(II) Complex in Simultaneous Reactivation of the Apoptotic Signaling Networks Against Human Colon Cancer Cells

  • NS

    Nima Samie 1,2*

  • BS

    Batoul Sadat Haerian 1

  • SM

    Sekaran Muniandy 3*

  • AM

    Anita Marlina 4

  • MS

    M. S. Kanthimathi 3,5

  • NB

    Norbani B. Abdullah 4

  • GA

    Gholamreza Ahmadian 6

  • RE

    Raja E. R. Aziddin 2

  • 1. Department of Pharmacology, Faculty of Medicine, University of Malaya Kuala Lumpur, Malaysia

  • 2. Drug and Research Unit, Department of Pathology, Hospital Kuala Lumpur Kuala Lumpur, Malaysia

  • 3. Department of Molecular Medicine, Faculty of Medicine, University of Malaya Kuala Lumpur, Malaysia

  • 4. Department of Chemistry, Faculty of Science, University of Malaya Kuala Lumpur, Malaysia

  • 5. Faculty of Medicine, University of Malaya Centre for Proteomics Research, University of Malaya Kuala Lumpur, Malaysia

  • 6. Department of Environmental and Industrial Biotechnology, National Institute of Genetic Engineering and Biotechnology Tehran, Iran

This article has been retracted. Please follow the link to the full retraction notice for details.

Summary

Citation

Samie N, Haerian BS, Muniandy S, Marlina A, Kanthimathi MS, Abdullah NB, Ahmadian G and Aziddin RER (2016) RETRACTED: Mechanism of Action of the Novel Nickel(II) Complex in Simultaneous Reactivation of the Apoptotic Signaling Networks Against Human Colon Cancer Cells. Front. Pharmacol. 6:313. doi: 10.3389/fphar.2015.00313

Received

19 November 2015

Accepted

18 December 2015

Published

28 January 2016

Volume

6 - 2015

Edited by

Olivier Cuvillier, Centre National de la Recherche Scientifique, France

Reviewed by

Stefania Nobili, University of Florence, Italy; Maryna Van De Venter, Nelson Mandela Metropolitan University, South Africa

Updates

This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics